{"id":"NCT00482729","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)","officialTitle":"A Randomized, Double-Blind, Active-Comparator Controlled, Clinical Trial to Study the Efficacy and Safety of MK0431A for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-06-19","primaryCompletion":"2008-11-03","completion":"2009-04-27","firstPosted":"2007-06-05","resultsPosted":"2010-03-15","lastUpdate":"2017-06-09"},"enrollment":1246,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"sitagliptin phosphate (+) metformin hydrochloride","otherNames":["MK0431A","Janumetâ„¢"]},{"type":"DRUG","name":"metformin","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to investigate the efficacy and safety of an investigational treatment for type 2 diabetes mellitus.","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (A1C) at Week 18","timeFrame":"Baseline and Week 18","effectByArm":[{"arm":"Sita/Met FDC","deltaMin":-2.37,"sd":null},{"arm":"Metformin","deltaMin":-1.76,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21410627","21535346"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":28,"n":625},"commonTop":["Any Gastrointestinal Disorders","Diarrhoea","Any Infections and infestations","Nausea","Upper respiratory tract infection"]}}